PeptiDream Inc (PPTDF)
17.00
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
PeptiDream Shareholders Equity (Quarterly): 365.20M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 365.20M |
| March 31, 2024 | 264.18M |
| December 31, 2023 | 286.12M |
| September 30, 2023 | 250.77M |
| June 30, 2023 | 214.23M |
| March 31, 2023 | 238.75M |
| December 31, 2022 | 244.38M |
| September 30, 2022 | 169.40M |
| June 30, 2022 | 181.12M |
| March 31, 2022 | 202.16M |
| December 31, 2021 | 220.29M |
| September 30, 2021 | 221.19M |
| June 30, 2021 | 200.34M |
| March 31, 2021 | 197.18M |
| December 31, 2020 | 205.72M |
| September 30, 2020 | 164.70M |
| June 30, 2020 | 163.70M |
| March 31, 2020 | 153.94M |
| September 30, 2019 | 159.93M |
| June 30, 2019 | 161.72M |
| March 31, 2019 | 138.83M |
| December 31, 2018 | 138.64M |
| Date | Value |
|---|---|
| September 30, 2018 | 129.75M |
| June 30, 2018 | 133.08M |
| March 31, 2018 | 108.61M |
| December 31, 2017 | 103.84M |
| September 30, 2017 | 103.04M |
| June 30, 2017 | 108.73M |
| March 31, 2017 | 93.51M |
| December 31, 2016 | 90.72M |
| September 30, 2016 | 107.12M |
| June 30, 2016 | 99.63M |
| March 31, 2016 | 79.75M |
| December 31, 2015 | 59.43M |
| September 30, 2015 | 57.98M |
| June 30, 2015 | 56.34M |
| March 31, 2015 | 49.27M |
| December 31, 2014 | 49.74M |
| September 30, 2014 | 53.67M |
| June 30, 2014 | 57.81M |
| March 31, 2014 | 56.56M |
| December 31, 2013 | 55.69M |
| September 30, 2013 | 58.43M |
| June 30, 2013 | 57.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
153.94M
Minimum
Mar 2020
365.20M
Maximum
Jun 2024
219.08M
Average
209.97M
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 48.46B |
| Nxera Pharma Co Ltd | 428.64M |
| Healios KK | 20.16M |
| AnGes Inc | 158.32M |
| SanBio Co Ltd | 10.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 595.81M |
| Total Liabilities (Quarterly) | 230.61M |
| Debt to Equity Ratio | 0.3561 |
| Current Ratio | 3.385 |
| Net Debt Paydown Yield | 0.22% |